131 related articles for article (PubMed ID: 17043962)
1. [Clinical analysis of 60 cases with malignant gastrointestinal stromal tumors].
Lin F; Cao J; Xia JT; Huang CM; DU H; Chen GQ; Wen MJ; Dai LH; Lai YY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):409-11. PubMed ID: 17043962
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience in diagnosis and treatment of malignant gastrointestinal stromal tumors.
Lin F; Cao J; Gu WL; Fan SF; Li KP; Du H; Chen GQ; Wen MJ; Dai LH; Lai YY
Kaohsiung J Med Sci; 2012 Apr; 28(4):212-5. PubMed ID: 22453069
[TBL] [Abstract][Full Text] [Related]
3. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
4. [Expression of CD117, CD34, SMA, S-100 protein, Vim and desmin in patients with gastrointestinal stromal tumors].
Liu J; Liu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):438-40. PubMed ID: 18359707
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
[TBL] [Abstract][Full Text] [Related]
6. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
7. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
Lam MM; Corless CL; Goldblum JR; Heinrich MC; Downs-Kelly E; Rubin BP
Int J Gynecol Pathol; 2006 Jul; 25(3):288-92. PubMed ID: 16810068
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of gastrointestinal stromal tumors: a study of 96 patients].
Lou YL; Chen H; Zhang XL; Zhan ZL
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):437-9. PubMed ID: 15355652
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of gastrointestinal stromal tumor: a report of 29 patients].
Qin HD; Zhang DW; Yang WL
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):139-41. PubMed ID: 16555155
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
12. Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature.
Vij M; Agrawal V; Pandey R
JOP; 2011 Mar; 12(2):200-4. PubMed ID: 21386653
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.
Mussi C; Schildhaus HU; Gronchi A; Wardelmann E; Hohenberger P
Clin Cancer Res; 2008 Jul; 14(14):4550-5. PubMed ID: 18628470
[TBL] [Abstract][Full Text] [Related]
14. A study of histopathological assessment criteria for assessing malignancy of gastrointestinal stromal tumor, from a clinical standpoint.
Yokoi K; Tanaka N; Shoji K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Yamashita K; Ohaki Y; Tajiri T
J Gastroenterol; 2005 May; 40(5):467-73. PubMed ID: 15942711
[TBL] [Abstract][Full Text] [Related]
15. Could imatinib replace surgery in esophageal gastrointestinal stromal tumor.
Al-Salam S; El-Teraifi HA; Taha MS
Saudi Med J; 2006 Aug; 27(8):1236-9. PubMed ID: 16883460
[TBL] [Abstract][Full Text] [Related]
16. Gastric GISTs. Personal experience.
Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
[TBL] [Abstract][Full Text] [Related]
17. Gastro-intestinal stromal tumour--role of CD117 in diagnosis and management.
Paul PC; Chakraborty J; Kundu D; Sarkar R
Indian J Pathol Microbiol; 2007 Apr; 50(2):279-83. PubMed ID: 17883045
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
19. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]